Haitao Pan
Affiliations: | 2017 | Biostatistics | The University of Texas MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences |
| 2017- | Biostatistics | St. Jude's Research Hospital |
Area:
Bayesin statistics, clinical trialsWebsite:
https://www.stjude.org/directory/p/haitao-pan.htmlGoogle:
"Haitao Pan"Parents
Sign in to add mentor| Clifton David Fuller | grad student | 2017 | UT MD Anderson Cancer Center (MPROTree) | |
| (Thesis: "NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES".) | ||||
| Ying Yuan | grad student | 2017 | UT MD Anderson Cancer Center | |
| (Thesis: "NOVEL BAYESIAN ADAPTIVE CLINICAL TRIAL DESIGNS IN EARLY PHASES".) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li C, Sun H, Cheng C, et al. (2022) A software tool for both the maximum tolerated dose and the optimal biological dose finding trials in early phase designs. Contemporary Clinical Trials Communications. 30: 100990 |
| Su X, Li Y, Müller P, et al. (2022) A semi-mechanistic dose-finding design in oncology using pharmacokinetic/pharmacodynamic modeling. Pharmaceutical Statistics |
| Wu J, Pan H, Hsu CW. (2022) Two-stage screened selection designs for randomized phase II trials with time-to-event endpoints. Biometrical Journal. Biometrische Zeitschrift |
| Mu R, Hu Z, Xu G, et al. (2021) An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials. Bmc Medical Research Methodology. 21: 278 |
| Mu R, Xu G, Liu G, et al. (2021) A two-stage Bayesian adaptive design for minimum effective dose (MinED)-based dosing-finding trials. Contemporary Clinical Trials. 106504 |
| Wu J, Pan H, Hsu CW. (2021) Bayesian single-arm phase II trial designs with time-to-event endpoints. Pharmaceutical Statistics |
| Mu R, Pan H, Xu G. (2020) A Bayesian adaptive phase I/II platform trial design for pediatric immunotherapy trials. Statistics in Medicine |
| Li C, Pan H. (2020) A phase I dose-finding design with incorporation of historical information and adaptive shrinking boundaries. Plos One. 15: e0237254 |
| Pan H, Cheng C, Yuan Y. (2020) Bayesian adaptive linearization method for phase I drug combination trials with dimension reduction. Pharmaceutical Statistics |
| Pan H, Lin R, Zhou Y, et al. (2020) Keyboard design for phase I drug-combination trials. Contemporary Clinical Trials. 105972 |